Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	270.65	290.87	264.55	270.5	157.64	137.98
Cash & Short-Term Investments	270.65	290.87	264.55	270.5	157.64	137.98
Cash Growth	4.56%	9.95%	-2.20%	71.60%	14.25%	-12.69%
Accounts Receivable	253.1	216.02	184.33	135.04	131.31	122.42
Other Receivables	3.73	16.63	23.59	26.38	10.84	10.31
Receivables	256.83	232.65	207.92	161.42	142.15	132.72
Inventory	297.32	293.17	248.55	243.07	235.18	222.19
Prepaid Expenses	-	3.33	5.39	2.08	6.52	1.9
Total Current Assets	824.8	820.02	726.4	677.07	541.49	494.8
Property, Plant & Equipment	549.68	554.11	567.52	582.37	579.92	542.53
Long-Term Investments	14.33	16.48	22.67	36.91	42.15	73.54
Other Intangible Assets	35.87	6.37	7.32	7.65	3.84	4.95
Long-Term Deferred Tax Assets	20.72	22.62	15.33	8.95	13.33	12.7
Long-Term Deferred Charges	-	30.52	37.55	31.15	40.14	34.58
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.05	1.05
Total Assets	1,446	1,451	1,378	1,345	1,222	1,164
Accounts Payable	166.08	53.98	55.89	40.45	51.93	31.32
Accrued Expenses	-	83.4	46.92	33.79	40.46	61.2
Short-Term Debt	-	29.09	32.33	50.59	101.8	87.85
Current Portion of Long-Term Debt	141.06	118.34	15.66	14.95	32.34	15.08
Current Portion of Leases	-	0.72	0.55	0.92	0.94	0.64
Current Income Taxes Payable	7.37	4.29	0.74	0.37	1.17	6.06
Other Current Liabilities	-	25.14	25.89	25.65	35.95	28.17
Total Current Liabilities	314.5	314.96	177.99	166.73	264.59	230.31
Long-Term Debt	341.09	345.47	464.52	480.9	294.6	297.8
Long-Term Leases	-	2.47	2.76	1.48	1.92	2.48
Long-Term Deferred Tax Liabilities	30.96	30.64	23.42	8.91	5.58	9.54
Total Liabilities	689.1	693.54	668.68	658.01	566.7	540.13
Common Stock	432.47	432.47	432.47	432.47	419.37	405.86
Retained Earnings	409.94	408.57	354.78	319.07	288.37	239.97
Comprehensive Income & Other	-85.05	-83.41	-78.09	-64.41	-52.52	-21.82
Shareholders' Equity	757.35	757.62	709.15	687.12	655.22	624
Total Liabilities & Equity	1,446	1,451	1,378	1,345	1,222	1,164
Total Debt	482.14	496.08	515.82	548.85	431.6	403.84
Net Cash (Debt)	-211.49	-205.21	-251.28	-278.35	-273.97	-265.86
Net Cash Per Share	-0.22	-0.21	-0.26	-0.29	-0.29	-0.29
Filing Date Shares Outstanding	962.79	961.94	961.94	961.94	952.24	941.77
Total Common Shares Outstanding	962.79	961.94	961.94	961.94	952.24	941.77
Working Capital	510.3	505.07	548.42	510.34	276.9	264.49
Book Value Per Share	0.79	0.79	0.74	0.71	0.69	0.66
Tangible Book Value	721.48	751.26	701.84	679.47	651.38	619.06
Tangible Book Value Per Share	0.75	0.78	0.73	0.71	0.68	0.66
Land	-	65.68	65.68	65.68	69.88	69.88
Buildings	-	269.88	267.09	265.86	125.23	124.51
Machinery	-	467.96	452.39	435.18	368.47	308.94
Construction In Progress	-	14.52	12.19	8.48	172.65	162.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.